Get started
Author

Ranokhon Igamberdieva

Observed names: R. IGAMBERDIEVA, R. Igamberdieva, R.Sh. Igamberdieva Igamberdieva, R.Sh. Igamberdiyeva Igamberdiyeva, RANOKHON IGAMBERDIEVA, Rano Igamberdieva, Ranokhon Sh. Igamberdieva
ORCID: 0000-0002-7314-0309
Observed ORCID: 0000-0002-7314-0309
OpenAlex ID: A5077665204
#3055 Association of Mortality With Intradialytic Exercise in Hemodialysis Patients
2023 · Sherzod Abdullaev, Ranokhon Igamberdieva · Nephrology Dialysis Transplantation · 2
PDF
Epidemiological, clinical and morphological aspects of kidney damage in COVID-19
2021 · Batir Daminov, Sherzod Abdullaev, et al. · Journal of Renal Injury Prevention · 2
PDF
#1912 Assessment of the dynamics of renal anemia in patients with atrial fibrillation and chronic kidney disease stage IIIb-V during anticoagulant therapy
2024 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation · 1
PDF
#3896 Safety Outcomes of Oral Anticoagulant Therapy in Patients With Atrial Fibrillation and Chronic Kidney Disease
2023 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation · 1
PDF
MO182: Safety Analysis of Anticoagulant Therapy in Stage 4 CKD in Combination with AF
2022 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation · 1
Mo123use of Rivaroxaban Versus Warfarin in Patients With Atrial Fibrillation and Advanced Chronic Kidney Disease*
2021 · Sherzod Abdullaev, Rano Igamberdieva, et al. · Nephrology Dialysis Transplantation · 1
PDF
Kidney damage in Covid-19: clinical-pathogenetic aspects and management of patients with chronic kidney disease
2021 · Sh. S.Abdullaev Abdullaev, R.Sh. Igamberdiyeva Igamberdiyeva, et al. · Kliničeskaâ nefrologiâ · 1
Effect of Oral Semaglutide on Residual Albuminuria in Patients with Diabetic Kidney Disease Despite Standard Nephroprotective Therapy
2026 · Ranokhon Igamberdieva, Botir Daminov · Journal of the American Society of Nephrology
Wcn26-7478 Association Between Urinary Tubular Injury Markers and Bleeding Risk in Patients With Atrial Fibrillation and Chronic Kidney Disease Receiving Rivaroxaban
2026 · Ranokhon Igamberdieva, Sherzod Abdullaev · Kidney International Reports
Abstract 4369641: The impact of renal injury markers on bleeding risk in chronic kidney disease and atrial fibrillation patients receiving rivaroxaban
2025 · RANOKHON IGAMBERDIEVA, Sherzod Abdullaev · Circulation
#1825 Monitoring of atrial indicators in patients with chronic kidney disease and atrial fibrillation after radio-frequency ablation
2025 · Ranokhon Igamberdieva, Sherzod Abdullaev, et al. · Nephrology Dialysis Transplantation
#2598 Impact of empagliflozin on metabolic profile, anthropometric indices, and renal function in chronic kidney disease patients with non-alcoholic fatty liver disease
2025 · Rakhimjon Tursunbayev, Sherzod Abdullaev, et al. · Nephrology Dialysis Transplantation
#1800 Cardiorenal relationships: correlation analysis of the effect of metabolic syndrome components on renal and cardiac function in heart failure patients with mid-range ejection fraction
2025 · Muzaffar Asomov, Gulchehra Atakhodjayeva, et al. · Nephrology Dialysis Transplantation
#1857 The efficacy and safety of using various combinations of antithrombotic therapy in patients with AF and ESKD undergoing program hemodialysis
2025 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation
PDF
Po-05-193 Comparative Assessment of the Safety and Efficacy of Rivaroxaban and Warfarin in Atrial Fibrillation in Elderly Patients With Chronic Kidney Disease Stage 4
2025 · Ranokhon Igamberdieva, Sherzod Abdullaev · Heart Rhythm
Wcn25-3811 Progression of Anticoagulant-related Nephropathy After Anticoagulant Therapy
2025 · Sherzod Abdullaev, Ranokhon Igamberdieva · Kidney International Reports
PDF
#2562 Effect of rituximab on post-transplant outcome in highly sensitized patients
2024 · Sherzod Abdullaev, Ranokhon Igamberdieva · Nephrology Dialysis Transplantation
PDF
#1986 Incidence of renal anemia among patients with atrial fibrillation and chronic kidney disease stage IIIb-V
2024 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation
PDF
#1994 Analysis of dynamics of parameters of safety and effectiveness of rivaroxaban in patients with stage IV chronic kidney disease and atrial fibrillation
2024 · Ranokhon Igamberdieva, Sherzod Abdullaev · Nephrology Dialysis Transplantation
#377 Assessment of kidney function by creatinine and cystatin C and cardiovascular outcomes in patients with atrial fibrillation
2024 · Sherzod Abdullaev, Ranokhon Igamberdieva · Nephrology Dialysis Transplantation
PDF
#206 The effect of dapagliflozin on anemia in patients with CKD
2024 · Sherzod Abdullaev, Ranokhon Igamberdieva · Nephrology Dialysis Transplantation
PDF
PB0023 Oral Anticoagulants in Patients with Atrial Fibrillation and Comorbid Conditions
2023 · S. Abdullaev, R. Igamberdieva · Research and Practice in Thrombosis and Haemostasis
OC 74.5 Safety Outcomes of Oral Anticoagulant Therapy in Patients with Atrial Fibrillation and Chronic Kidney Disease
2023 · R. Igamberdieva, S. Abdullaev · Research and Practice in Thrombosis and Haemostasis
PDF
PB0019 Direct Oral Anticoagulants and Risk of Kidney Disease
2023 · S. Abdullaev, R. Igamberdieva · Research and Practice in Thrombosis and Haemostasis
#2765 Evaluation of Antibody Responses to Sars-cov-2 Vaccines in Patients With Ckd
2023 · Sherzod Abdullaev, Olimkhon Sharapov, et al. · Nephrology Dialysis Transplantation
PDF
Works count: 37
Citation count: 9
H-index: 2
I10-index:
Year
Topic
Type